Research and Development

The Research and Development team at Providence Therapeutics is focused on advancing the science behind personalized mRNA cancer vaccines. This multidisciplinary group conducts preclinical and nonclinical studies, formulates mRNA constructs, and develops analytical methods to ensure vaccine efficacy and safety. By collaborating closely, team members aim to innovate and refine therapeutic solutions specifically targeting ovarian cancer.